The Role of Pseudomonas aeruginosa Lipopolysaccharide in Bacterial Pathogenesis and Physiology

被引:122
|
作者
Huszczynski, Steven M. [1 ]
Lam, Joseph S. [1 ]
Khursigara, Cezar M. [1 ]
机构
[1] Univ Guelph, Dept Mol & Cellular Biol, 50 Stone Rd E, Guelph, ON N1G 2W1, Canada
来源
PATHOGENS | 2020年 / 9卷 / 01期
基金
加拿大健康研究院;
关键词
lipopolysaccharide; O antigen; host-pathogen interactions; cystic fibrosis; biofilms; antimicrobial resistance; pyocin; ANTIGEN CHAIN-LENGTH; ENTERICA SEROVAR TYPHIMURIUM; O-ANTIGEN; OUTER-MEMBRANE; CYSTIC-FIBROSIS; LIPID-A; SERUM RESISTANCE; CORE OLIGOSACCHARIDE; MOLECULAR-BASIS; AMINOGLYCOSIDE RESISTANCE;
D O I
10.3390/pathogens9010006
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The major constituent of the outer membrane of Gram-negative bacteria is lipopolysaccharide (LPS), which is comprised of lipid A, core oligosaccharide, and O antigen, which is a long polysaccharide chain extending into the extracellular environment. Due to the localization of LPS, it is a key molecule on the bacterial cell wall that is recognized by the host to deploy an immune defence in order to neutralize invading pathogens. However, LPS also promotes bacterial survival in a host environment by protecting the bacteria from these threats. This review explores the relationship between the different LPS glycoforms of the opportunistic pathogen Pseudomonas aeruginosa and the ability of this organism to cause persistent infections, especially in the genetic disease cystic fibrosis. We also discuss the role of LPS in facilitating biofilm formation, antibiotic resistance, and how LPS may be targeted by new antimicrobial therapies.
引用
收藏
页数:22
相关论文
共 50 条
  • [41] The role of Type III secretion system in the pathogenesis of Pseudomonas aeruginosa microbial keratitis
    Yang, Justin J.
    Tsuei, Kai-Si Claire
    Shen, Elizabeth P.
    TZU CHI MEDICAL JOURNAL, 2022, 34 (01): : 8 - 14
  • [42] Effect of Phthalates and Their Substitutes on the Physiology of Pseudomonas aeruginosa
    Louis, Melissande
    Tahrioui, Ali
    Verdon, Julien
    David, Audrey
    Rodrigues, Sophie
    Barreau, Magalie
    Manac'h, Maeliss
    Thiroux, Audrey
    Luton, Baptiste
    Dupont, Charly
    Le Calve, Marie
    Bazire, Alexis
    Crepin, Alexandre
    Clabaut, Maximilien
    Portier, Emilie
    Taupin, Laure
    Defontaine, Florian
    Clamens, Thomas
    Bouffartigues, Emeline
    Cornelis, Pierre
    Feuilloley, Marc
    Caillon, Jocelyne
    Dufour, Alain
    Berjeaud, Jean-Marc
    Lesouhaitier, Olivier
    Chevalier, Sylvie
    MICROORGANISMS, 2022, 10 (09)
  • [43] BACTERIAL ENDOCARDITIS DUE TO PSEUDOMONAS AERUGINOSA
    LLOYD, KM
    GORDON, JN
    ANNALS OF INTERNAL MEDICINE, 1961, 55 (05) : 814 - +
  • [44] BACTERIAL ENDOCARDITIS DUE TO PSEUDOMONAS AERUGINOSA
    WAISBREN, BA
    HASTINGS, EV
    AMA ARCHIVES OF PATHOLOGY, 1953, 55 (03): : 218 - 222
  • [45] BACTERIAL ENDOCARDITIS DUE TO PSEUDOMONAS AERUGINOSA
    GOTTSEGEN, G
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1958, 168 (14): : 1929 - 1930
  • [46] BACTERIAL HEMAGGLUTININ OF PSEUDOMONAS-AERUGINOSA
    GILBOAGA.N
    MIZRAHI, L
    ISRAEL JOURNAL OF MEDICAL SCIENCES, 1972, 8 (05): : 673 - &
  • [47] Pseudomonas aeruginosa - a phenomenon of bacterial resistance
    Strateva, Tanya
    Yordanov, Daniel
    JOURNAL OF MEDICAL MICROBIOLOGY, 2009, 58 (09) : 1133 - 1148
  • [48] Evaluating Bacterial Pathogenesis Using a Model of Human Airway Organoids Infected with Pseudomonas aeruginosa Biofilms
    Tang, Mingxing
    Liao, Shumin
    Qu, Jing
    Liu, Yixin
    Han, Shuhong
    Cai, Zhao
    Fan, Yunping
    Yang, Liang
    Li, Shuo
    Li, Liang
    MICROBIOLOGY SPECTRUM, 2022, 10 (06):
  • [49] Molecular mechanisms of bacterial virulence elucidated using a Pseudomonas aeruginosa Caenorhabditis elegans pathogenesis model
    Mahajan-Miklos, S
    Tan, MW
    Rahme, LG
    Ausubel, FM
    CELL, 1999, 96 (01) : 47 - 56
  • [50] Pathogenesis of septic shock in Pseudomonas aeruginosa pneumonia
    Kurahashi, K
    Kajikawa, O
    Sawa, T
    Ohara, M
    Gropper, MA
    Frank, DW
    Martin, TR
    Wiener-Kronish, JP
    JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (06): : 743 - 750